Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures

China has one of the highest carrier prevalences of hepatitis B virus (HBV) in the world: nearly 10% of the general population. The disease burden of HBV infection and hepatocellular carcinoma (HCC) is also believed to be among the world’s largest, and that of hepatitis C virus (HCV) infection is li...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Masahiro, Katayama, Francisco, Kato, Hideaki, Tanaka, Hideo, Wang, Jianbing, Qiao, You Lin, Inoue, Manami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Epidemiological Association 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899457/
https://www.ncbi.nlm.nih.gov/pubmed/22041528
http://dx.doi.org/10.2188/jea.JE20100190
_version_ 1782300581124112384
author Tanaka, Masahiro
Katayama, Francisco
Kato, Hideaki
Tanaka, Hideo
Wang, Jianbing
Qiao, You Lin
Inoue, Manami
author_facet Tanaka, Masahiro
Katayama, Francisco
Kato, Hideaki
Tanaka, Hideo
Wang, Jianbing
Qiao, You Lin
Inoue, Manami
author_sort Tanaka, Masahiro
collection PubMed
description China has one of the highest carrier prevalences of hepatitis B virus (HBV) in the world: nearly 10% of the general population. The disease burden of HBV infection and hepatocellular carcinoma (HCC) is also believed to be among the world’s largest, and that of hepatitis C virus (HCV) infection is likely to be substantial as well. However, the epidemiology and measures to control HBV and HCV infection in China remain relatively unknown outside the country. We review the epidemiology of HBV and HCV infection, the disease burden of and risk factors for HCC, and current control measures against HBV and HCV infection in China. We also discuss the relevant literature and implications for future studies of hepatitis and HCC in China.
format Online
Article
Text
id pubmed-3899457
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Japan Epidemiological Association
record_format MEDLINE/PubMed
spelling pubmed-38994572014-02-04 Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures Tanaka, Masahiro Katayama, Francisco Kato, Hideaki Tanaka, Hideo Wang, Jianbing Qiao, You Lin Inoue, Manami J Epidemiol Review Article China has one of the highest carrier prevalences of hepatitis B virus (HBV) in the world: nearly 10% of the general population. The disease burden of HBV infection and hepatocellular carcinoma (HCC) is also believed to be among the world’s largest, and that of hepatitis C virus (HCV) infection is likely to be substantial as well. However, the epidemiology and measures to control HBV and HCV infection in China remain relatively unknown outside the country. We review the epidemiology of HBV and HCV infection, the disease burden of and risk factors for HCC, and current control measures against HBV and HCV infection in China. We also discuss the relevant literature and implications for future studies of hepatitis and HCC in China. Japan Epidemiological Association 2011-11-05 /pmc/articles/PMC3899457/ /pubmed/22041528 http://dx.doi.org/10.2188/jea.JE20100190 Text en © 2011 Japan Epidemiological Association. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review Article
Tanaka, Masahiro
Katayama, Francisco
Kato, Hideaki
Tanaka, Hideo
Wang, Jianbing
Qiao, You Lin
Inoue, Manami
Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures
title Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures
title_full Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures
title_fullStr Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures
title_full_unstemmed Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures
title_short Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures
title_sort hepatitis b and c virus infection and hepatocellular carcinoma in china: a review of epidemiology and control measures
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899457/
https://www.ncbi.nlm.nih.gov/pubmed/22041528
http://dx.doi.org/10.2188/jea.JE20100190
work_keys_str_mv AT tanakamasahiro hepatitisbandcvirusinfectionandhepatocellularcarcinomainchinaareviewofepidemiologyandcontrolmeasures
AT katayamafrancisco hepatitisbandcvirusinfectionandhepatocellularcarcinomainchinaareviewofepidemiologyandcontrolmeasures
AT katohideaki hepatitisbandcvirusinfectionandhepatocellularcarcinomainchinaareviewofepidemiologyandcontrolmeasures
AT tanakahideo hepatitisbandcvirusinfectionandhepatocellularcarcinomainchinaareviewofepidemiologyandcontrolmeasures
AT wangjianbing hepatitisbandcvirusinfectionandhepatocellularcarcinomainchinaareviewofepidemiologyandcontrolmeasures
AT qiaoyoulin hepatitisbandcvirusinfectionandhepatocellularcarcinomainchinaareviewofepidemiologyandcontrolmeasures
AT inouemanami hepatitisbandcvirusinfectionandhepatocellularcarcinomainchinaareviewofepidemiologyandcontrolmeasures

Ejemplares similares